![Yael Gothelf](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Yael Gothelf formerly worked at Interpharm Laboratories Ltd., as Scientific Manager-Research & Process Development and Brainstorm Cell Therapeutics, Inc., as Vice President-Scientific & Regulatory Affairs from 2007 to 2024.
Dr. Gothelf received her doctorate degree from Tel-Aviv University.
Eerdere bekende functies van Yael Gothelf
| Bedrijven | Functie | Einde |
|---|---|---|
| BRAINSTORM CELL THERAPEUTICS INC. | Hoofd Techniek/Wetenschap/O&O | 01-01-2024 |
Interpharm Laboratories Ltd.
 Interpharm Laboratories Ltd. BiotechnologyHealth Technology Develops recombinant cytokines for the treatment of viral infections, cancer and autoimmune diseases | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Yael Gothelf
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
27
Eerstegraads connecties
3
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Brainstorm Cell Therapeutics, Inc.
 Brainstorm Cell Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company, which develops innovative adult stem cell therapeutic products | Health Technology |
Tel-Aviv University
 Tel-Aviv University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Interpharm Laboratories Ltd.
Interpharm Laboratories Ltd. BiotechnologyHealth Technology Develops recombinant cytokines for the treatment of viral infections, cancer and autoimmune diseases | Health Technology |
Kies MarketScreener 
